Promising antitumor activity of olaparib against heavily pretreated mCRPC with DDR gene defects June 3, 2019
Phase III studies of Xolair in chronic rhinosinusitis with nasal polyps meet coprimary endpoints June 3, 2019
Jiangsu Hengrui Medicine's camrelizumab receives first approval in China for treatment of lymphoma June 3, 2019
RSS